Verified ComparisonLast updated: 17 April 2026
CJC-1295 vs Ipamorelin
CJC-1295 is a GHRH analog. Ipamorelin acts on the ghrelin receptor. Combined, they target two GH-release pathways at once.
CJC-1295
GH Releasing
4.3/ 5
A−
Ipamorelin
GH Secretagogue
4.3/ 5
A−
Editor's note
These are mechanistically complementary — they're more often combined than directly substituted.
| Criterion | CJC-1295 | Ipamorelin |
|---|---|---|
| Mechanism | GHRH-R agonist | GHS-R / ghrelin receptor agonist |
| Half-life | Long (with DAC) | Short |
| Selectivity | GHRH pathway | Selective GH release |
| Used together? | Yes — common pairing | Yes — common pairing |
Frequently asked questions
In research literature they are typically combined, not substituted. Each addresses a different pathway.
Want to read the full reviews?